Premature ovarian insufficiency stems from dysregulated FOXO3 signaling that disrupts mitochondrial dynamics in granulosa cells, triggering senescence and reproductive failure. This mechanism appears conserved in both chemically-induced and age-related ovarian decline, positioning mitochondrial function as a tractable intervention point for preserving ovarian reserve.
Key Points
- FOXO3 phosphorylation loss drives mitochondrial fission, ATP depletion, and granulosa senescence
- Spatial transcriptomics maps distinct senescent cell populations within failing follicular structure
- Identical FOXO3-mitochondrial dysfunction signature appears in both drug-induced and physiological o
Longevity Analysis
Ovarian aging represents a primary driver of female lifespan and health span compression. This research maps a specific molecular circuit—FOXO3-regulated mitochondrial homeostasis—that controls whether reproductive cells maintain function or enter senescence. The finding that pharmacological modulation of this pathway can partially reverse mitochondrial dysfunction in cultured cells suggests intervention windows exist before follicular depletion becomes irreversible. More broadly, FOXO3 orchestrates cellular energy production, waste clearance, and stress resilience across multiple tissues; understanding its role in ovarian biology informs how systemic metabolic health connects to reproductive longevity. The spatial resolution reveals that senescence does not occur uniformly—distinct cell populations experience different degenerative trajectories—which matters for designing therapies that target specific vulnerable subsets rather than blanket interventions.
Original published by Wiley Aging Cell, by Ziwei Song, Yaoli Yin, Meilin Chen, Xiaolu Jin, Zemin Li, Hongxiao Li, Meihong Shen .